Study Details

Back
Study ID 1226-CL-A003
Study Title Long-term Treatment Study of CDP870 Self-injection.(Original language of CSR synopsis is Japanese.)
Clinicaltrials.gov Identifier NCT02586246
Compound Name CDP870 / certolizumab pegol
Medical Indication or Disease Rheumatoid arthritis
Study Sponsor Astellas Pharma Inc.
Collaborator UCB Japan Co. Ltd.
Study Start Date 25-Jan-2011
Study Completion Date 28-May-2013
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS